REDWOOD CITY, Calif.--(BUSINESS WIRE)--Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device ...

Oracle has expanded its move into pharmaceutical innovation by investing an undisclosed “minor” sum in Proteus Digital Health, a company that has developed ingestible and wearable sensors. Proteus’ ...

After years of using its digital health feedback system in clinical trials and studies, Proteus Digital Health, and partner Otsuka Pharmaceuticals, are poised to launch the first mass market drug to ...

REDWOOD CITY, Calif. – July 30, 2012 – Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device ...

Proteus takes a meticulous, “anti-Theranos” approach to growth and navigating the hurdles of creating a new category of medical device. Following Theranos’ fraudulent unraveling, two separate Food and ...

Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month. That ...

Would a notification from your doctor as soon as you forget to take your medication help keep you on track? A digital medicine company called Proteus is betting the answer is yes. The Silicon ...

With Proteus Digital Health's tracker riding in a tablet treating mental health disorders, patients (and their caregivers and doctors) will be able to tell that the medicine has been ingested. A ...

The Japanese drug maker Otsuka has been approved to purchase the assets of bankrupt smart pill maker Proteus Digital Health for $15 million — capping off a spectacular fall for Proteus, which raised ...

Proteus Digital Health has announced it has received FDA clearance for an ingestible sensor, according to a news release. The ingestible sensor, formally referred to as the Ingestion Event Marker, can ...